Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 9 | 2019 | 822 | 1.620 |
Why?
|
Ventricular Remodeling | 26 | 2011 | 1261 | 1.520 |
Why?
|
Matrix Metalloproteinases | 14 | 2011 | 392 | 1.340 |
Why?
|
Matrix Metalloproteinase 9 | 9 | 2010 | 632 | 0.820 |
Why?
|
Myocardial Contraction | 12 | 2009 | 1516 | 0.750 |
Why?
|
Myocardium | 23 | 2011 | 4700 | 0.740 |
Why?
|
Myocardial Infarction | 23 | 2011 | 11891 | 0.680 |
Why?
|
Ventricular Function, Left | 15 | 2011 | 3880 | 0.640 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 9 | 2011 | 97 | 0.640 |
Why?
|
Matrix Metalloproteinase 2 | 10 | 2010 | 461 | 0.570 |
Why?
|
Heart Arrest, Induced | 4 | 2006 | 357 | 0.560 |
Why?
|
Matrix Metalloproteinase 14 | 7 | 2011 | 60 | 0.550 |
Why?
|
Glutens | 2 | 2015 | 240 | 0.510 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2009 | 479 | 0.410 |
Why?
|
Endopeptidases | 1 | 2015 | 772 | 0.380 |
Why?
|
Immunomodulation | 1 | 2015 | 547 | 0.370 |
Why?
|
Diet, Gluten-Free | 4 | 2019 | 280 | 0.370 |
Why?
|
Myocytes, Cardiac | 8 | 2010 | 1657 | 0.360 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 4 | 2005 | 151 | 0.340 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8552 | 0.340 |
Why?
|
Swine | 21 | 2011 | 5899 | 0.340 |
Why?
|
Duodenum | 1 | 2012 | 486 | 0.330 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 239 | 0.320 |
Why?
|
Endotoxins | 1 | 2010 | 521 | 0.300 |
Why?
|
Endothelin-1 | 2 | 2006 | 302 | 0.290 |
Why?
|
Finite Element Analysis | 1 | 2010 | 428 | 0.290 |
Why?
|
Models, Cardiovascular | 2 | 2010 | 978 | 0.290 |
Why?
|
Heart Conduction System | 2 | 2010 | 1015 | 0.280 |
Why?
|
Oligopeptides | 4 | 2015 | 1187 | 0.280 |
Why?
|
Aorta, Thoracic | 6 | 2010 | 1097 | 0.270 |
Why?
|
Fibrinolysin | 3 | 2011 | 131 | 0.270 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2010 | 698 | 0.260 |
Why?
|
Aprotinin | 3 | 2011 | 94 | 0.260 |
Why?
|
Animals, Newborn | 1 | 2010 | 2672 | 0.250 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 138 | 0.240 |
Why?
|
Cytokines | 5 | 2017 | 7343 | 0.240 |
Why?
|
Protein Kinase C | 2 | 2006 | 1199 | 0.240 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7593 | 0.240 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 68 | 0.240 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2010 | 819 | 0.230 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 613 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 951 | 0.220 |
Why?
|
Radiation Injuries, Experimental | 1 | 2003 | 88 | 0.220 |
Why?
|
Heart-Assist Devices | 3 | 2010 | 1291 | 0.220 |
Why?
|
Heart Injuries | 1 | 2005 | 208 | 0.220 |
Why?
|
Muscle Cells | 1 | 2004 | 195 | 0.220 |
Why?
|
Hydroxamic Acids | 2 | 2003 | 482 | 0.220 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 3022 | 0.210 |
Why?
|
Antifibrinolytic Agents | 3 | 2010 | 292 | 0.210 |
Why?
|
Heart | 4 | 2011 | 4393 | 0.200 |
Why?
|
Enzyme Activation | 6 | 2010 | 3602 | 0.200 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2002 | 241 | 0.200 |
Why?
|
Random Allocation | 7 | 2010 | 2394 | 0.200 |
Why?
|
Microdialysis | 6 | 2011 | 160 | 0.190 |
Why?
|
Enzyme Inhibitors | 5 | 2005 | 3726 | 0.190 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2255 | 0.190 |
Why?
|
Temperature | 2 | 2006 | 2221 | 0.180 |
Why?
|
Ventricular Pressure | 3 | 2010 | 204 | 0.180 |
Why?
|
Biocompatible Materials | 1 | 2008 | 1689 | 0.170 |
Why?
|
Animals | 50 | 2011 | 167963 | 0.170 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2010 | 189 | 0.170 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 179 | 0.160 |
Why?
|
Disease Models, Animal | 18 | 2010 | 18137 | 0.160 |
Why?
|
Collagen | 10 | 2011 | 2636 | 0.160 |
Why?
|
Enzyme Induction | 4 | 2006 | 452 | 0.160 |
Why?
|
Isoenzymes | 4 | 2006 | 1690 | 0.150 |
Why?
|
Tranexamic Acid | 2 | 2010 | 176 | 0.150 |
Why?
|
Cardiopulmonary Bypass | 3 | 2010 | 1096 | 0.140 |
Why?
|
Hemodynamics | 10 | 2010 | 4174 | 0.140 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 1173 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2010 | 5785 | 0.130 |
Why?
|
Computer Simulation | 1 | 2010 | 6218 | 0.130 |
Why?
|
Caspases | 3 | 2010 | 878 | 0.130 |
Why?
|
Hookworm Infections | 1 | 2015 | 17 | 0.130 |
Why?
|
Endothelins | 2 | 2006 | 127 | 0.120 |
Why?
|
Echocardiography | 6 | 2010 | 4981 | 0.120 |
Why?
|
Peptides | 2 | 2006 | 4354 | 0.120 |
Why?
|
Rewarming | 2 | 2004 | 64 | 0.120 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 453 | 0.120 |
Why?
|
Cardioplegic Solutions | 2 | 2004 | 122 | 0.120 |
Why?
|
Transglutaminases | 1 | 2015 | 197 | 0.110 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 416 | 0.110 |
Why?
|
Catheter Ablation | 2 | 2005 | 2758 | 0.110 |
Why?
|
Enterocytes | 1 | 2015 | 220 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2010 | 2128 | 0.110 |
Why?
|
Heart Failure | 5 | 2010 | 11847 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2015 | 606 | 0.100 |
Why?
|
Tight Junctions | 1 | 2015 | 315 | 0.100 |
Why?
|
Fibroblasts | 4 | 2010 | 4090 | 0.100 |
Why?
|
Mice | 20 | 2011 | 81208 | 0.100 |
Why?
|
Fibrinolysis | 2 | 2010 | 332 | 0.100 |
Why?
|
Heart Ventricles | 7 | 2010 | 3811 | 0.100 |
Why?
|
Sus scrofa | 3 | 2010 | 433 | 0.090 |
Why?
|
Probiotics | 1 | 2015 | 377 | 0.090 |
Why?
|
Protease Inhibitors | 2 | 2006 | 755 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 951 | 0.090 |
Why?
|
Durapatite | 1 | 2011 | 163 | 0.090 |
Why?
|
Systole | 2 | 2010 | 947 | 0.090 |
Why?
|
Diastole | 2 | 2010 | 788 | 0.080 |
Why?
|
Heart Rate | 3 | 2010 | 4179 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1612 | 0.080 |
Why?
|
Time Factors | 12 | 2010 | 40165 | 0.080 |
Why?
|
Compliance | 1 | 2009 | 100 | 0.080 |
Why?
|
Acetylcysteine | 1 | 2010 | 264 | 0.080 |
Why?
|
Heart Septal Defects | 1 | 2010 | 191 | 0.080 |
Why?
|
Metalloendopeptidases | 3 | 2005 | 393 | 0.080 |
Why?
|
Calpain | 1 | 2009 | 145 | 0.080 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 527 | 0.080 |
Why?
|
Cardiotonic Agents | 2 | 2009 | 546 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2006 | 575 | 0.080 |
Why?
|
Thoracotomy | 1 | 2010 | 363 | 0.080 |
Why?
|
Up-Regulation | 4 | 2010 | 4122 | 0.080 |
Why?
|
Immunohistochemistry | 8 | 2011 | 11071 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3157 | 0.080 |
Why?
|
Microspheres | 1 | 2011 | 787 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2010 | 866 | 0.080 |
Why?
|
Microinjections | 1 | 2008 | 321 | 0.070 |
Why?
|
Injections, Intralesional | 1 | 2008 | 278 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 409 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1057 | 0.070 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 5209 | 0.070 |
Why?
|
Dogs | 2 | 2010 | 3841 | 0.070 |
Why?
|
Protein Kinase C-epsilon | 1 | 2006 | 43 | 0.070 |
Why?
|
Probability | 2 | 2010 | 2475 | 0.070 |
Why?
|
Vaccines | 1 | 2015 | 832 | 0.070 |
Why?
|
Chemokines | 1 | 2010 | 962 | 0.070 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2006 | 60 | 0.070 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 697 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1067 | 0.070 |
Why?
|
Myocardial Reperfusion | 2 | 2006 | 347 | 0.070 |
Why?
|
Hemostatics | 1 | 2009 | 243 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 593 | 0.070 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1726 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1959 | 0.060 |
Why?
|
Connexin 43 | 1 | 2006 | 200 | 0.060 |
Why?
|
Hyperkalemia | 2 | 2004 | 231 | 0.060 |
Why?
|
Mice, Transgenic | 5 | 2010 | 9530 | 0.060 |
Why?
|
Stroke Volume | 5 | 2010 | 5523 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2010 | 815 | 0.060 |
Why?
|
Isotonic Solutions | 1 | 2004 | 116 | 0.060 |
Why?
|
Sheep | 4 | 2011 | 1441 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2001 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1023 | 0.060 |
Why?
|
Male | 28 | 2017 | 359744 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 4925 | 0.060 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2003 | 142 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2803 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3758 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8056 | 0.050 |
Why?
|
Depression, Chemical | 1 | 2002 | 185 | 0.050 |
Why?
|
Guanidines | 1 | 2003 | 193 | 0.050 |
Why?
|
Calcium Chloride | 3 | 2010 | 78 | 0.050 |
Why?
|
Endocardium | 1 | 2003 | 246 | 0.050 |
Why?
|
Adrenomedullin | 1 | 2002 | 85 | 0.050 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2002 | 45 | 0.050 |
Why?
|
Gene Deletion | 3 | 2006 | 2668 | 0.050 |
Why?
|
Radio Waves | 1 | 2003 | 250 | 0.050 |
Why?
|
Recovery of Function | 2 | 2010 | 2985 | 0.050 |
Why?
|
Humans | 21 | 2020 | 760621 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2003 | 691 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3520 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2010 | 6238 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1303 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2011 | 43 | 0.050 |
Why?
|
Blood Pressure | 4 | 2010 | 8525 | 0.050 |
Why?
|
Sulfones | 1 | 2003 | 447 | 0.050 |
Why?
|
Disease Progression | 7 | 2006 | 13502 | 0.040 |
Why?
|
Aging | 2 | 2009 | 8651 | 0.040 |
Why?
|
Heart Atria | 1 | 2006 | 1346 | 0.040 |
Why?
|
Female | 20 | 2017 | 391270 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2006 | 18957 | 0.040 |
Why?
|
Cicatrix | 1 | 2005 | 782 | 0.040 |
Why?
|
Electrocardiography | 2 | 2010 | 6414 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2234 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1964 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22023 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2004 | 758 | 0.040 |
Why?
|
Kidney | 4 | 2011 | 7064 | 0.040 |
Why?
|
Quadriceps Muscle | 2 | 2010 | 154 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14660 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1323 | 0.040 |
Why?
|
Organ Size | 1 | 2003 | 2254 | 0.040 |
Why?
|
Fibrosis | 3 | 2010 | 2042 | 0.040 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 2 | 2010 | 72 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2005 | 2272 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 2010 | 687 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2011 | 12766 | 0.040 |
Why?
|
Caspase 3 | 2 | 2010 | 731 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17790 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10756 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4048 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1636 | 0.030 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2009 | 148 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1311 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 305 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2002 | 1031 | 0.030 |
Why?
|
Actins | 3 | 2010 | 2049 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 643 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 65017 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20080 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2117 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2164 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5797 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2009 | 1666 | 0.030 |
Why?
|
Genes, Reporter | 2 | 2009 | 1529 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 524 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 2014 | 211 | 0.030 |
Why?
|
Angiotensin II | 2 | 2009 | 849 | 0.030 |
Why?
|
Troponin I | 2 | 2010 | 638 | 0.030 |
Why?
|
Postoperative Period | 2 | 2010 | 1818 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2011 | 10827 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2002 | 1419 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1697 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 102 | 0.020 |
Why?
|
Thallium Radioisotopes | 1 | 2011 | 138 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4573 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2011 | 145 | 0.020 |
Why?
|
Middle Aged | 8 | 2017 | 220352 | 0.020 |
Why?
|
Survival | 1 | 2011 | 161 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 987 | 0.020 |
Why?
|
Fibrillar Collagens | 1 | 2010 | 42 | 0.020 |
Why?
|
Intestine, Small | 1 | 2017 | 1207 | 0.020 |
Why?
|
Ultrasonography | 3 | 2010 | 5961 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5725 | 0.020 |
Why?
|
Th17 Cells | 1 | 2017 | 787 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 5990 | 0.020 |
Why?
|
Gelatinases | 1 | 2010 | 88 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 2010 | 174 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1827 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2913 | 0.020 |
Why?
|
Microbubbles | 1 | 2010 | 128 | 0.020 |
Why?
|
Lac Operon | 1 | 2009 | 237 | 0.020 |
Why?
|
Microscopy, Confocal | 2 | 2005 | 1972 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12293 | 0.020 |
Why?
|
Myosins | 1 | 2010 | 405 | 0.020 |
Why?
|
Injections | 1 | 2011 | 830 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6538 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 680 | 0.020 |
Why?
|
Elastin | 1 | 2009 | 301 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1725 | 0.020 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2010 | 418 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2011 | 14372 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 9287 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20509 | 0.020 |
Why?
|
Apoptosis | 3 | 2009 | 9501 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3448 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1385 | 0.020 |
Why?
|
Elasticity | 1 | 2009 | 652 | 0.020 |
Why?
|
Signal Transduction | 4 | 2011 | 23376 | 0.020 |
Why?
|
Adult | 5 | 2017 | 219994 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2006 | 242 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 516 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 44 | 0.020 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 14 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2006 | 410 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2005 | 34 | 0.020 |
Why?
|
Gap Junctions | 1 | 2006 | 230 | 0.020 |
Why?
|
Heart Block | 1 | 2006 | 392 | 0.010 |
Why?
|
Organ Specificity | 1 | 2009 | 1955 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2852 | 0.010 |
Why?
|
Aged | 5 | 2017 | 169152 | 0.010 |
Why?
|
Liver | 2 | 2010 | 7509 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2005 | 532 | 0.010 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 1046 | 0.010 |
Why?
|
Heart Septum | 1 | 2005 | 303 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3465 | 0.010 |
Why?
|
Age Factors | 2 | 2013 | 18416 | 0.010 |
Why?
|
Creatine Kinase, MB Form | 1 | 2003 | 211 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2004 | 345 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 22053 | 0.010 |
Why?
|
Benzenesulfonates | 1 | 2003 | 165 | 0.010 |
Why?
|
Electrolytes | 1 | 2004 | 274 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 3075 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1913 | 0.010 |
Why?
|
Hematologic Tests | 1 | 2004 | 238 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2003 | 319 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5039 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4773 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2005 | 658 | 0.010 |
Why?
|
Chymases | 1 | 2002 | 73 | 0.010 |
Why?
|
Angiotensin I | 1 | 2002 | 56 | 0.010 |
Why?
|
Alabama | 1 | 2002 | 104 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 519 | 0.010 |
Why?
|
Xanthines | 1 | 2002 | 122 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3562 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1649 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2006 | 948 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15697 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6377 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6544 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1485 | 0.010 |
Why?
|
Renin | 1 | 2002 | 635 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8803 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2086 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1720 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1653 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2003 | 663 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10547 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1843 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12965 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1630 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6381 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 58741 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13308 | 0.010 |
Why?
|
Infant | 2 | 2010 | 36060 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1347 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1577 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4357 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2825 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 1021 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5305 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2003 | 1108 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7588 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4925 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15687 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2015 | 80372 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1523 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2004 | 1921 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13451 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8950 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9335 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17624 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10182 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13981 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2525 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23711 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2788 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 2221 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5745 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4611 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6479 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 87810 | 0.000 |
Why?
|
United States | 1 | 2015 | 72461 | 0.000 |
Why?
|
Phenotype | 1 | 2004 | 16546 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 74359 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 54303 | 0.000 |
Why?
|